AAVs show potential for kidney gene therapy, however, kidney gene transfer remains challenging. Here, the authors show that differing viral capsids exhibit distinct delivery to tubules and podocytes which is also dependent on injection routes, disease state and species.
- Taisuke Furusho
- Ranjan Das
- Hiroyuki Nakai
